AADI BIOSCIENCE INC (AADI) Institutional Ownership Changes & 13F Activity
AADI BIOSCIENCE INC (AADI). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Yu Fan, Acuta Capital Partners, Llc, Adar1 Capital Management, Llc, Suvretta Capital Management, Llc, and Balyasny Asset Management L.P..
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| State Street Corp | Buy | +226,600 | +141.3% | 386,982 | $1.77M | Q2 2026 | Sep 22, 2026 |
| Citadel Advisors Llc | Sell | -61,766 | -67.2% | 30,086 | $137.79K | Q2 2026 | Sep 02, 2026 |
| Yu Fan | Buy | +2,791,314 | +134.8% | 4,861,314 | $22.26M | Q2 2026 | Aug 14, 2026 |
| Acuta Capital Partners, Llc | Buy | +1,275,510 | +37.4% | 4,685,912 | $21.46M | Q2 2026 | Aug 14, 2026 |
| Adar1 Capital Management, Llc | Buy | +1,212,891 | +943.9% | 1,341,394 | $6.14M | Q2 2026 | Aug 14, 2026 |
| Suvretta Capital Management, Llc | Buy | +600,000 | +16.2% | 4,300,000 | $19.69M | Q2 2026 | Aug 14, 2026 |
| Balyasny Asset Management L.P. | Sell | -262,324 | -47.7% | 288,117 | $1.32M | Q2 2026 | Aug 14, 2026 |
| Orbimed Advisors Llc | Sell | -231,704 | -5.6% | 3,934,296 | $18.02M | Q2 2026 | Aug 14, 2026 |
| Verdad Advisers, Lp | Buy | +185,999 | +161.1% | 301,483 | $1.38M | Q2 2026 | Aug 14, 2026 |
| Woodline Partners Lp | Buy | +155,117 | +55.1% | 436,614 | $2.00M | Q2 2026 | Aug 14, 2026 |
| Stempoint Capital Lp | Buy | +81,668 | +8.7% | 1,021,037 | $4.68M | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +78,832 | — | 78,832 | $361.05K | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Buy | +70,732 | +22.8% | 380,406 | $1.74M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Buy | +69,846 | +122.7% | 126,758 | $580.55K | Q2 2026 | Aug 14, 2026 |
| Bridgeway Capital Management, Llc | Sell | -50,000 | -23.2% | 165,284 | $757.00K | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +39,179 | — | 39,179 | $179.44K | Q2 2026 | Aug 14, 2026 |
| Point72 Asset Management, L.P. | Buy | +29,103 | +103.8% | 57,129 | $261.65K | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Buy | +27,174 | — | 27,174 | $124.46K | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +26,609 | — | 26,609 | $122.00K | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +23,130 | +8.5% | 296,612 | $1.36M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Sell | -18,235 | -34.5% | 34,626 | $158.59K | Q2 2026 | Aug 14, 2026 |
| Mirae Asset Global Etfs Holdings Ltd. | Buy | +14,942 | — | 14,942 | $68.43K | Q2 2026 | Aug 14, 2026 |
| Scientech Research Llc | Buy | +10,838 | — | 10,838 | $49.64K | Q2 2026 | Aug 14, 2026 |
| Two Sigma Securities, Llc | Buy | +10,033 | — | 10,033 | $45.95K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +5,786 | +894.3% | 6,433 | $29.46K | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Sell | -4,461 | -19.4% | 18,522 | $84.83K | Q2 2026 | Aug 14, 2026 |
| Eversept Partners, Lp | Sell | -3,494 | -1.1% | 303,306 | $1.39M | Q2 2026 | Aug 14, 2026 |
| Legal & General Group Plc | Buy | +3,162 | — | 3,162 | $14.48K | Q2 2026 | Aug 14, 2026 |
| Royal Bank Of Canada | Buy | +937 | +529.4% | 1,114 | $5.00K | Q2 2026 | Aug 14, 2026 |
| Qube Research & Technologies Ltd | Buy | +686 | +1.4% | 48,993 | $224.39K | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about AADI activity
Which institutional owners are buying AADI?
Institutional owners buying AADI include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in AADI activity?
"Buy" means an investor increased their reported position in AADI compared to the prior reporting period. This reflects growing exposure to AADI BIOSCIENCE INC (AADI) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in AADI increasing?
Institutional interest in AADI can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related AADI Institutional Insights
- AADI Overview
- AADI 13F Institutional Holders
- AADI Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- AADI Insider Trading & SEC Form 4 Activity
- AADI Articles
- Top Institutional Investor Stock Rankings